Literature DB >> 20827215

Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.

Virginia A Triant1, Susan Regan, Hang Lee, Paul E Sax, James B Meigs, Steven K Grinspoon.   

Abstract

BACKGROUND: The effects of immunologic and virologic factors on acute myocardial infarction (AMI) rates in patients with HIV are unclear.
METHODS: HIV-infected patients in a US healthcare system were assessed for AMI.
RESULTS: Of 6517 patients with HIV, 273 (4.2%) had an AMI. In a model adjusting for cardiovascular risk factors, antiretroviral medications, and HIV parameters, CD4 count less than 200/mm (odds ratio, 1.74; 95% confidence interval, 1.07 to 2.81; P = 0.02) predicted AMI. Increased HIV viral load was associated with AMI accounting for cardiovascular disease risk factors and antiretroviral medications but was not significant when CD4 count was considered.
CONCLUSIONS: Immunologic control appears to be the most important HIV-related factor associated with AMI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827215      PMCID: PMC3036774          DOI: 10.1097/QAI.0b013e3181f4b752

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  14 in total

1.  Coronary heart disease in HIV-infected individuals.

Authors:  Judith S Currier; Anne Taylor; Felicity Boyd; Christopher M Dezii; Hugh Kawabata; Beth Burtcel; Jen-Fue Maa; Sally Hodder
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

2.  Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

Authors:  Robert C Kaplan; Lawrence A Kingsley; Stephen J Gange; Lorie Benning; Lisa P Jacobson; Jason Lazar; Kathryn Anastos; Phyllis C Tien; A Richey Sharrett; Howard N Hodis
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

3.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

4.  Association of C-reactive protein and HIV infection with acute myocardial infarction.

Authors:  Virginia A Triant; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

5.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

6.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

7.  Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.

Authors:  F Bonnet; G Chêne; R Thiébaut; M Dupon; S Lawson-Ayayi; J L Pellegrin; F Dabis; P Morlat
Journal:  HIV Med       Date:  2007-11       Impact factor: 3.180

8.  Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.

Authors: 
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

9.  Extracting principal diagnosis, co-morbidity and smoking status for asthma research: evaluation of a natural language processing system.

Authors:  Qing T Zeng; Sergey Goryachev; Scott Weiss; Margarita Sordo; Shawn N Murphy; Ross Lazarus
Journal:  BMC Med Inform Decis Mak       Date:  2006-07-26       Impact factor: 2.796

10.  Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

Authors:  Andrew N Phillips; Andrew Carr; Jacquie Neuhaus; Fehmida Visnegarwala; Ronald Prineas; William J Burman; Ian Williams; Fraser Drummond; Daniel Duprez; Waldo H Belloso; Frank-Detlef Goebel; Birgit Grund; Angelos Hatzakis; Jose Vera; Jens D Lundgren
Journal:  Antivir Ther       Date:  2008
View more
  81 in total

Review 1.  Management of the metabolic effects of HIV and HIV drugs.

Authors:  Todd T Brown; Marshall J Glesby
Journal:  Nat Rev Endocrinol       Date:  2011-09-20       Impact factor: 43.330

Review 2.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 3.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

4.  Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania.

Authors:  Catharina Armstrong; Enju Liu; James Okuma; Donna Spiegelman; Chalamilla Guerino; Marina Njelekela; Steve Grinspoon; Wafaie Fawzi; Claudia Hawkins
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

5.  Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.

Authors:  Virginia A Triant; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

Review 6.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 7.  Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.

Authors:  John Charles A Lacson; Revery P Barnes; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

8.  Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection.

Authors:  Mark J Siedner; Virginia Triant
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

9.  Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study.

Authors:  Shawnbir Gogia; Alexandra Coromilas; Susan Regan; Lauren Stone; Lindsay T Fourman; Virginia A Triant; Tomas G Neilan; Markella V Zanni
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

10.  Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.

Authors:  Rushi V Parikh; Rebecca Scherzer; Carl Grunfeld; Elaine M Nitta; Anna Leone; Jeffrey N Martin; Steven G Deeks; Peter Ganz; Priscilla Y Hsue
Journal:  Atherosclerosis       Date:  2013-04-30       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.